missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ UCHL3 Recombinant Rabbit Monoclonal Antibody (001)
GREENER_CHOICE

Rabbit Recombinant Monoclonal Antibody

Brand:  Invitrogen™ MA560321

Product Code. 30534957

  • £357.00 / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

UCHL3 Recombinant Monoclonal Antibody for ELISA

Regulatory associated protein of mTOR (RAPTOR) is a binding partner of target of rapamycin (TOR). It binds to 4EBP1 and p70alpha. The binding of raptor to mTOR is essential for the mTOR-catalyzed phosphorylation of 4EBP1 in vitro. It enhances the mTOR kinase activity toward p70alpha. It is also an essential scaffold for the mTOR-catalyzed phosphorylation of 4EBP1 and mediates TOR action in vivo.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

UCHL3
Recombinant Monoclonal
1 mg/mL
PBS with no preservative
P15374
UCHL3
Recombinant Human UCHL3 protein (Glu2-Ala230).
100 μL
Primary
Human
Antibody
IgG
ELISA
001
Unconjugated
UCHL3
RGD1561196; testicular tissue protein Li 221; ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase); ubiquitin carboxyl-terminal hydrolase isozyme L3; ubiquitin C-terminal hydrolase L3; Ubiquitin thioesterase L3; ubiquitin thiolesterase; UCHL3; UCH-L3
Rabbit
Protein A
RUO
7347
-20°C, Avoid Freeze/Thaw Cycles
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.